Melanoma Matters13 Helmi 2025

Ep 59: 2024 Reflections

Time to exhale... and reflect upon 2024.

In this episode, hosts Sapna Patel and James Larkin reflect on their professional and personal experiences from 2024, discussing highlights, lowlights, and the impact of loss in the medical community. They share their intentions and goals for 2025, emphasizing personal bests, leadership , and the importance of friendships. The conversation also touches on cultural reflections, including movies, books, and music, culminating in heartfelt poetry for the New Year.

Keywords

2025 intentions, professional highlights, personal growth, medical community, cultural reflections, leadership challenges, loss, achievements, goals, aspirations

Takeaways

The importance of being in the arena and taking risks.

FDA approval of lifileucel marks a significant milestone.

Loss in the medical community deeply affects personal and professional lives.

Transitioning to new roles can bring self-doubt and challenges.

Celebrating achievements is crucial for personal growth.

Setting intentions for the new year can guide personal and professional goals.

Friendships are foundational to our well-being and happiness.

Looking ahead with optimism.

Titles

Reflections on 2024: Intentions for 2025

Navigating Professional Highlights and Lowlights

Sound Bites

"I want to read the Malcolm Gladwell book."

"Cheers to 2025!"

"It's been one hell of a 365."

Chapters

00:00 2024 Reflections and 2025 Intentions

03:41 Professional Highlights and Lowlights

06:02 Personal Growth and Career Transitions

08:17 Leadership and Self-Doubt

10:44 Memorable Experiences and Connections

12:16 Personal and Professional Intertwining

12:37 Looking Ahead to 2025

17:18 Personal Bests: A Metaphor for Life

18:19 Literary Adventures: Books and Insights

19:07 Cinematic Experiences: Movies of the Year

26:05 Looking Ahead: Goals for 2025

32:06 Reflections and New Year Wishes

33:55 Fact Check

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(93)

Ep 88: Negative Adjuvant Doublet Studies (CM915, KV010, RELA098)

Melanoma Matters: Why Adjuvant Doublet Immunotherapy Fell ShortHobbies - James wishes he was surfing more This episode breaks down three negative adjuvant melanoma trials testing combination immunothe...

1 Syys 22min

Ep 86: Teaser Tudriqev (RP1) FDA Approval

James asks the big question

25 Elo 10s

Ep 87: INTerpath-001 Press Release - August 2026

In this episode, Sapna and James discuss the INTerpath-001 press release describing primary endpoint (RFS) and key secondary endpoint (DMFS) findings from the randomized phase 3 study of individualize...

25 Elo 12min

Ep 86: Tudriqev (RP1) FDA Approval

In this episode, James and Sapna debate how to pronounce the newest FDA approved treatment for melanoma: T-U-D-R-I-Q-E-VThey discuss the FDA Cell and Gene Therapy Advisory Committee's review of the si...

25 Elo 52min

Ep 85: Surgical considerations for TIL

In this episode, Sapna and James talk tv shows - The Gambler and His Cowboys, Brassic... They discuss the paper from NKI on surgical considerations for TIL harvest published in BJS in 2025. Topics of ...

28 Heinä 29min

Ep 84: Merlin CP-GEP and Castle i31-SLNB tests

In this episode, the chin dimple is front and center. James explains the wizarding home of Tintagel in Cornwall to Sapna, situated on a lovely promontory. This episode explores the latest evidence on ...

24 Heinä 35min

Ep 83: Guest Megan Othus and Time of Day Administration

James and Sapna welcome Megan Othus, Professor of Biostatistics at the Fred Hutch Cancer Center and one of the key statisticians at SWOG.Megan talks about growing up in the PNW and going East to get b...

24 Kesä 40min

Ep 82: Best of ASCO: 2026

In this episode, James & Sapna tease the size of ASCO and ESMO and number of simultaneous publications.They review the most impactful melanoma and Merkel cell carcinoma presentations from ASCO 2026, f...

13 Kesä 1h 4min